Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lund

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Diabetes Research and Clinical Practice|May 27, 2026
Comprehensive drug safety assessment of sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors: A Danish population-based active comparator new user cohort studyLars Christian Lund, Emma Simonsen, Anton Pottegård
British Journal of Clinical Pharmacology|December 20, 2025
Screening real-world data for evidence of unsuspected drug benefits: An application of the sequence symmetry analysisMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Acta Psychiatrica Scandinavica|November 7, 2023
Smoking and severe mental illness: Drawing inference on the directionality of the association requires careful consideration of the temporality of the dataMarie Krab Lund, Mikkel Højlund, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|November 1, 2023
Trend adjustment of the sequence difference when performing sequence symmetry analysesMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|May 20, 2025
Obtaining Valid Compatibility Intervals for Sequence Symmetry Analyses Utilizing Active Comparators: A Simulation StudyMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|April 9, 2021
Online tool to create publication ready graphical depictions of longitudinal study design implemented in healthcare databasesLars Christian Lund, Jesper Hallas, Shirley V Wang
Pharmacoepidemiology and Drug Safety|August 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrheaMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Ugeskrift for Laeger|April 26, 2018
[Treatment of vancomycin-resistant enterococcal infections]Lars Christian Lund, Barbara Juliane Holzknecht, Ulrik Stenz Justesen
JAMA Neurology|February 5, 2024
Risk of Stroke and Myocardial Infarction Among Initiators of TriptansChristian Lund Petersen, Anders Hougaard, David Gaist, et al.
Acta Psychiatrica Scandinavica|June 17, 2024
Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adultsHelene Kildegaard, Rikke Wesselhoeft, Lars Christian Lund, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Diabetes Research and Clinical Practice|May 27, 2026
Comprehensive drug safety assessment of sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors: A Danish population-based active comparator new user cohort studyLars Christian Lund, Emma Simonsen, Anton Pottegård
British Journal of Clinical Pharmacology|December 20, 2025
Screening real-world data for evidence of unsuspected drug benefits: An application of the sequence symmetry analysisMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Acta Psychiatrica Scandinavica|November 7, 2023
Smoking and severe mental illness: Drawing inference on the directionality of the association requires careful consideration of the temporality of the dataMarie Krab Lund, Mikkel Højlund, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|November 1, 2023
Trend adjustment of the sequence difference when performing sequence symmetry analysesMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|May 20, 2025
Obtaining Valid Compatibility Intervals for Sequence Symmetry Analyses Utilizing Active Comparators: A Simulation StudyMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|April 9, 2021
Online tool to create publication ready graphical depictions of longitudinal study design implemented in healthcare databasesLars Christian Lund, Jesper Hallas, Shirley V Wang
Pharmacoepidemiology and Drug Safety|August 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrheaMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Ugeskrift for Laeger|April 26, 2018
[Treatment of vancomycin-resistant enterococcal infections]Lars Christian Lund, Barbara Juliane Holzknecht, Ulrik Stenz Justesen
JAMA Neurology|February 5, 2024
Risk of Stroke and Myocardial Infarction Among Initiators of TriptansChristian Lund Petersen, Anders Hougaard, David Gaist, et al.
Acta Psychiatrica Scandinavica|June 17, 2024
Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adultsHelene Kildegaard, Rikke Wesselhoeft, Lars Christian Lund, et al.
Pageof 13